GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shortwave Life Sciences PLC (AQSE:PSY) » Definitions » EPS (Basic)

Shortwave Life Sciences (AQSE:PSY) EPS (Basic) : £ (TTM As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Shortwave Life Sciences EPS (Basic)?

Shortwave Life Sciences's basic earnings per share (Basic EPS) for the six months ended in . 20 was £0.00. Shortwave Life Sciences does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Shortwave Life Sciences's EPS (Diluted) for the six months ended in . 20 was £0.00. Shortwave Life Sciences does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Shortwave Life Sciences's EPS without NRI for the six months ended in . 20 was £0.00. Shortwave Life Sciences does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Shortwave Life Sciences EPS (Basic) Historical Data

The historical data trend for Shortwave Life Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shortwave Life Sciences EPS (Basic) Chart

Shortwave Life Sciences Annual Data
Trend
EPS (Basic)

Shortwave Life Sciences Semi-Annual Data
EPS (Basic)

Shortwave Life Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shortwave Life Sciences's Basic EPS for the fiscal year that ended in . 20 is calculated as


Shortwave Life Sciences's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shortwave Life Sciences  (AQSE:PSY) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Shortwave Life Sciences EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Shortwave Life Sciences's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Shortwave Life Sciences Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Shortwave Life Sciences PLC is a biopharmaceutical company focused in advancing pioneering therapies in mental health care, also it is involved in developing novel drug combinations and delivery methods to treat patients suffering from mental health disorders. It identifies, operates and creates value from early-stage, breakthrough initiatives, with an initial focus on eating disorders.

Shortwave Life Sciences Headlines